Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors

Trimethoprim/sulfamethoxazole is the first-line agent for oral eradication therapy for melioidosis but has been associated with toxicity in this context. This study aimed to quantify adverse drug reactions (ADRs) to trimethoprim/sulfamethoxazole when used for treatment of melioidosis, and assess ris...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Genevieve E. Martin, Joshua Bramwell, Eden Gadil, Celeste Woerle, Thomas Ewin, Jane Davies, Sonja Janson, Bart J. Currie
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2025-01-01
Ráidu:	International Journal of Infectious Diseases
Fáttát:	Melioidosis Trimethoprim/sulfamethoxazole Adverse drug reaction Severe cutaneous adverse reaction
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1201971224003540
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!